Drug Agency Hikes Spending For Research

WASHINGTON—The National Institute on Drug Abuse will award more than $155 million in research funds this year. The 77 percent increase over last year is due largely to the President's initiative on drug abuse, and the drug-AIDS connection. Officials said $31 million will be directed toward AIDS research, a 340 percent increase over last year. The administration's $1.5 billion program to combat drugs, which includes funds for military interdiction and anti-crime measures, contains $27 milli

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Officials said $31 million will be directed toward AIDS research, a 340 percent increase over last year. The administration's $1.5 billion program to combat drugs, which includes funds for military interdiction and anti-crime measures, contains $27 million for drug-related research.

The deadline for grant proposals is February 1 for most fields of inquiry; however, an extension to April 1 has been provided in some areas. Among these are studies on AIDS prevention, cocaine, the pharmacokinetics of drug abuse and genetic vulnerability to drug abuse. (For more information, contact Marvin Snyder, (301) 443-1887, Division of Preclinical Research, or Roy Pickens, Division of Clinical Research, (301) 433-6697.)

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies